SEC Filing Analysis: GE HealthCare Technologies Inc. (GEHC)

Executive Summary

• Trading Significance: Low
• Key Takeaway: Chief People Officer Adam Holton received a routine equity compensation package consisting of RSUs and Stock Options.
• Market Impact: Neutral - Standard executive remuneration event.

Company Information

Field	Value
Company	GE HealthCare Technologies Inc.
Ticker Symbol	GEHC
CIK	0001932393
Industry	Medical Devices

Insider Information

Field	Value
Name	Holton Adam Y
CIK	0001657919
Title/Position	Chief People Officer
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2026-03-02
Transaction Code	A (Grant/Award)
Security Type	Common Stock (RSUs) & Options
Shares Involved	5,457 (RSUs)
Price Per Share	$0.00
Total Value	$0 (Grant)
Shares Owned After	22,225
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0 (Grant)
% of Market Cap	0.00%
Shares Transacted	5,457
% of Shares Outstanding	<0.002%
Post-Transaction Ownership	22,225 shares (<0.01% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: With a market capitalization of $38.41 billion, this compensation grant is financially immaterial to the company's balance sheet.
• Ownership Concentration: The insider holds a negligible percentage of the 455.75 million shares outstanding.
• Dilution Impact: The grant of 5,457 RSUs and 14,348 options represents <0.005% dilution, which is negligible for existing shareholders.
• Transaction Significance: This is a Code 'A' transaction (Grant), indicating compensation rather than an open market investment decision.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: Equity grants are a standard part of executive compensation and do not signal insider sentiment regarding future price movements.

Volume & Sentiment

• Expected Volume Impact: None.
• Sentiment Indicator: Neutral.

Additional Context

Transaction Notes

• Vesting Schedule: Both the RSUs and Options vest over three years (33% in 2027, 33% in 2028, 34% in 2029).
• Option Details: The 14,348 stock options have an exercise price of $80.16 and expire in 2036.
• Nature of Holding: The reporting person's direct ownership increased to 22,225 shares following this transaction.